After-Hours Stock Movers 08/03: (CERS) (NVTA) (ATVI) Higher; (ZY) (LPSN) (OSUR) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St futures drop as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Oil gains over 3% as US-Iran peace talks in stalemate
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
RingCentral (RNG) Bear Thesis Addressed at Mizuho
August 5, 2021 1:05 PM EDTMizuho Securities analyst Siti Panigrahi reiterated a Buy rating and $400.00 price target on RingCentral (NYSE: RNG) after addressing the bear thesis. The analyst sees a "compelling buying opportunity."
The analyst commented, "Despite strong Q2 results, RNG shares have sold off... More
Cerus (CERS) Appoints Ann Lucena to its Board
August 4, 2021 8:32 AM EDTCerus Corporation (Nasdaq: CERS) today announced the appointment of Ann Lucena, CEO of San Ramon Regional Medical Center (SRRMC), to its Board of Directors. SRRMC, a 123-bed acute care hospital located in the East Bay Area, is part of a joint venture involving Tenet Healthcare. She also serves as the chairperson of the board overseeing the joint venture between John Muir Health and San Ramon Regional Medical Center.
We are delighted to welcome Ann... More
Softbank-Backed Zymergen (ZY) Crashes Over 70% as CEO Departs, Product Revenue Not Possible in 2021 and 'Immaterial' in 2022, At Least 6 Firms Downgrade
August 4, 2021 7:14 AM EDTShares of Zymergen (NASDAQ: ZY) are down more than 70% in pre-open Wednesday after the company said it no longer expects product revenue in 2021, while the same will be immaterial in 2022.
During the quarter, several key target customers encountered technical issues in implementing Hyaline into their manufacturing processes typical of new product and process development learnings. The Company has made significant progress towards addressing these challenges and believes there are no intrinsic technical issues with Hyaline. However, this issue has resulted in a delay in the Companys commercial ramp. Zymergen is working to strengthen... More
Paycom Software (PAYC) PT Raised to $480 at Cowen
August 4, 2021 6:57 AM EDTCowen analyst Bryan Bergin raised the price target on Paycom Software (NYSE: PAYC) to $480.00 (from $475.00) while maintaining an Outperform rating.
The analyst commented, "A strong 2Q print with 4%/6% revenue/EBITDA beats and 3Q outlook also 3-4% above Street was delivered... More
Activision Blizzard (ATVI) PT Lowered to $105 at Oppenheimer
August 4, 2021 6:37 AM EDTOppenheimer analyst Andrew Uerkwitz lowered the price target on Activision Blizzard (NASDAQ: ATVI) to $105.00 (from $110.00) while maintaining an Outperform rating.
The analyst commented, "Working from home, unhappy employees, and leadership changes should all have a negative impact on productivity for game developers. We were... More
